Efficacy of Lanreotide Autogel/Depot (LAN) vs Placebo (PBO) for Symptomatic Control of Carcinoid Syndrome (CS) in Neuroendocrine Tumor (NET) Patients from the ELECT Study Wolin, E. M., Fisher, G. A., Kunz, P. L., Liyanage, N., Lowenthal, S., Mirakhur, B., Pommier, R. F., Shaheen, M., Vinik, A. NATURE PUBLISHING GROUP. 2016: S468

View details for Web of Science ID 000395764601507